Ottawa Heart Failure Risk Scale (OHFRS)
ورودیهای بالینی بیمار
پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.
- Low risk0–0
- Medium risk1–2
- High risk3–4
- Very high risk5–13
The Ottawa Heart Failure Risk Scale (OHFRS) calculates rapid bedside triage, risk stratification, and urgent clinical decision-making. Key inputs include stroke or tia. Scores guide determining acute hospital admission, emergency department discharge safety, or intensive care transfer. This standardized assessment improves clinical decision safety and bedside patient management.
Clinical Guidelines & Evidence
Identifies emergency department heart failure patients at high risk for serious adverse events. Uses 10 clinical variables to stratify risk from low (2.8%) to very high (89%+).
Clinical Indication
The Ottawa Heart Failure Risk Scale (OHFRS) is indicated for bedside clinical practice to support Identifies emergency department heart failure patients at high risk for serious adverse events. Uses 10 clinical variables to stratify risk from low (2.8%) to very high (89%+).. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.
Target Population
Target population comprises Adult and pediatric patients presenting with acute undifferentiated clinical complaints, trauma, or unstable vital signs. Clinical application is indicated across Emergency triage, acute resuscitation bays, observation units, and emergency trauma centers.
Limitations & Contraindications
Score calculations must never delay immediate life-saving airway stabilization, vascular access, or emergent surgical consult.
Clinical Pearls & Action Plan
Adherence to core ABCDE resuscitation principles and bedside clinical gestalt must take absolute precedence over numerical decision tools. Guideline pearl: High sensitivity: 91.8% without NT-proBNP, 95.8% with NT-proBNP.
OHFRS = (Stroke/TIA × 1) + (Intubation history × 2) + (HR ≥110 arrival × 2) + (SaO₂ <90% × 1) + (HR ≥110 walk test × 1) + (New ischemic ECG × 2) + (Urea ≥12 × 1) + (CO₂ ≥35 × 2) + (Troponin MI level × 2) + (NT-proBNP ≥5000 × 1)
Input Parameters
| Name | Type | Required | Description |
|---|---|---|---|
| stroke_or_tia | string | Yes | History of stroke or transient ischemic attack (TIA) |
| intubation_respiratory_distress | string | Yes | History of intubation for respiratory distress |
| heart_rate_110_or_higher_arrival | string | Yes | Heart rate ≥110 beats per minute on ED arrival |
| oxygen_saturation_less_than_90 | string | Yes | Oxygen saturation (SaO₂) <90% on arrival |
| heart_rate_110_or_higher_walk_test | string | Yes | Heart rate ≥110 beats per minute during 3-minute walk test |
| new_ischemic_changes_ecg | string | Yes | New ischemic changes on ECG (clinician interpretation) |
| urea_12_or_higher | string | Yes | Urea ≥12 mmol/L (≥33.6 mg/dL) |
| serum_co2_35_or_higher | string | Yes | Serum CO₂ ≥35 mmol/L |
| troponin_elevated_mi_level | string | Yes | Troponin I or T elevated to myocardial infarction level |
| nt_probnp_5000_or_higher | string | Yes | NT-proBNP ≥5,000 ng/L (≥5,000 pg/mL) |
Score Interpretation & Guidance
| Range | Stage | Description |
|---|---|---|
| 0–0 | Low risk | 2.8% risk of serious adverse events |
| 1–2 | Medium risk | 5.1-9.2% risk of serious adverse events |
| 3–4 | High risk | 15.9-26.1% risk of serious adverse events |
| 5–13 | Very high risk | 39.8-89%+ risk of serious adverse events |
Evidence-Based References (EBM)
- Stiell IG, Clement CM, Brison RJ, Rowe BH, Borgundvaag B, Aaron SD, et al. A risk scoring system to identify emergency department patients with heart failure at high risk for serious adverse events. Acad Emerg Med. 2013 Jan;20(1):17-26. doi: 10.1111/acem.12056.DOI: 10.1111/acem.12056
- Stiell IG, Perry JJ, Clement CM, Brison RJ, Rowe BH, Aaron SD, et al. Prospective and Explicit Clinical Validation of the Ottawa Heart Failure Risk Scale, With and Without Use of Quantitative NT-proBNP. Acad Emerg Med. 2017 Mar;24(3):316-327. doi: 10.1111/acem.13141.DOI: 10.1111/acem.13141